<DOC>
	<DOCNO>NCT01677585</DOCNO>
	<brief_summary>The purpose study compile real-world clinical outcome data PROMUS Element™ PROMUS Element™ Plus Everolimus-Eluting Coronary Stent System ( PROMUS Element PROMUS Element Plus Stent System ) routine clinical practice China .</brief_summary>
	<brief_title>Post-Approval Study PROMUS Element™ China</brief_title>
	<detailed_description>Everolimus-eluting stent study extensively ongoing clinical study . The safety effectiveness everolimus drug polymer combination study extensively SPIRIT Clinical Trial Program . The PROMUS Element stent currently study PLATINUM Clinical Trial Program . The PROMUS Element stent also evaluate PROMUS Element Plus US post-approval study ongoing Platinum China study . This study design provide post-market surveillance information PROMUS Element™ PROMUS Element™ Everolimus-Eluting Coronary Stent System ( PROMUS Element PROMUS Element Plus Stent System ) approve SFDA ( State Food Drug Administration ) China . The study evaluate clinical outcome subject receive PROMUS Element PROMUS Element plus stent 5 year real world set accord post approval requirement SFDA .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Subject must least 18 year age Subject understand provide write informed consent Subject clinically indicate attempt least one PROMUS Element stent OR Subject clinically indicate implant least one PROMUS Element stent Subject willing comply protocolrequired followup evaluation Exclusion criterion require PROMUS Element China PostApproval study `` comer '' study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>